Jupiter Endovascular Announces Positive Results From SPIRARE II Pivotal Trial
Jupiter Endovascular revealed positive results from its SPIRARE II pivotal trial presented at EuroPCR 2026, confirming that the trial met both of its primary endpoints.
MENLO PARK, Calif.–(BUSINESS WIRE)– #TFX–Jupiter Endovascular announced positive results from its SPIRARE II pivotal trial at EuroPCR showing the trial met both of its primary endpoints.